-
Product Name
Anti-CKIIalpha (5F9) Mouse antibody
- Documents
-
Description
CKIIalpha (5F9) Mouse monoclonal antibody
-
Tested applications
WB, FC
-
Species reactivity
Human, Mouse
-
Isotype
Mouse IgG1
-
Preparation
Antigen: Purified recombinant fragment of human CSNK2A2 (AA: 194-350) expressed in E. Coli.
-
Clonality
Monoclonal
-
Formulation
Ascitic fluid containing 0.03% sodium azide.
-
Storage instructions
Store at 4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.
-
Applications
WB: 1/500 - 1/2000
FC: 1/200 - 1/400
ELISA: 1/10000
-
Validations
Western blot detection of CKII alpha prime polypeptide in C6,Jurkat,K562,3T3 and Hela cell lysates using CKII alpha prime polypeptide mouse mAb (1:2000 diluted).Predicted band size:41KDa.Observed band size:41KDa.
Flow cytometric analysis of HepG2 cells using CSNK2A2 mouse mAb (green) and negative control (red).
Western blot analysis using CSNK2A2 mouse mAb against HeLa (1), MCF-7 (2), HepG2 (3), Jurkat (4), NIH3T3 (5), and PC-12 (6) cell lysate.
-
Background
Swiss-Prot Acc.P19784.Casein kinase II (CK2) is a constitutively active, ubiquitously expressed serine/threonine protein kinasethat is thought to have a regulatory function in cell proliferation, cell differentiation and apoptosis. CK2functions as a tetrameric complex consisting of two regulatory beta-subunits and two catalytic units (alphaand alpha') in a homomeric or heteromeric conformation. Whilst the alpha- and alpha'-subunits arecatalytically identical, proteins that regulate CK2, such as cdc2 and Hsp90, preferentially bind to thealpha and not the alpha'-subunit. CK2 can phosphorylate a number of key intracellular signaling proteinsimplicated in tumor suppression (p53 and PTEN) and tumorigenesis (myc, jun, NF-kappaB). CK2 is also thoughtto influence Wnt signaling via beta-catenin phosphorylation and the PI 3-K signaling pathway via thephosphorylation of Akt.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"